Stocks and InvestingStocks and Investing
Mon, July 18, 2022
Sat, July 16, 2022
Fri, July 15, 2022

Salveen Richter Upgraded (ALLO) to Strong Buy and Increased Target to $32 on, Jul 15th, 2022


Published on 2024-10-27 21:57:33 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Upgraded "Allogene Therapeutics, Inc." (ALLO) to Strong Buy and Increased Target from $9 to $32 on, Jul 15th, 2022.

Salveen has made no other calls on ALLO in the last 4 months.



There are 2 other peers that have a rating on ALLO. Out of the 2 peers that are also analyzing ALLO, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jack Allen of "Baird" Initiated at Hold and Held Target at $11 on, Friday, June 3rd, 2022


This is the rating of the analyst that currently disagrees with Salveen


  • Dane Leone of "Raymond James" Maintained at Buy with Decreased Target to $13 on, Thursday, May 5th, 2022